Here are four quick points:
1. Technological advancements and synthetic bone grafts will spur the market’s growth.
2. North America is expected to grow at a compound annual growth rate of 3.5 percent to 2023.
3. An increasing emphasis on patient safety will continue to drive the market’s growth in North America.
4. The allografts sector is expected to reach $1.15 billion by 2023, due to the transition from autografts to allografts.
More articles on devices:
Amedica, SI-BONE, Stryker & more: 14 key notes
Stryker completes CareFusion’s VCF acquisition: 5 takeaways
FDA panel finds Cartiva SCI safe, effective: 3 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
